Medical Oncology Expert Witnesses

Medical oncology expert witnesses and consultants listed here may be able to form expert opinions, draft expert witness reports, provide expert witness testimony at deposition and/or trial as or serve as consulting (non-testifying) experts on medical oncology. The medical oncology expert witness listings on this page are typically from fields/areas of expertise such as: Correctional Healthcare, Hematology, Internal Medicine, Oncology, and Pharmaceutical Regulation.

View Full Profile

Susan E. Lawrence, MD

Lancaster, California
Correctional Healthcare, Internal Medicine - Medical oncology, prisons, jails, ICE, immigration detention facilities, deliberate indifference, cancer treatment in prison, end of life care in prison, chronic disease management in prison, general inmate health care, correctional medical director, triage, delayed diagnosis, delayed treatment
Experienced Correctional Medicine Physician and Consultant. Double Board Certified (Internal Medicine and Medical Oncology), with additional areas of expertise in HIV/AIDS, viral hepatitis, and coccidioidomycosis. Educated at Barnard College of Columbia University and and Baylor College of Medicine. Founder/former CEO of nonprofit HIV/AIDS organization and and founder of FQHC (Federally Qualified Health Center) for underserved populations. Skilled expert witness with extensive experience in records review, report writing, and deposition/trial testimony. Award winning writer and public speaker. Licensed in California and Indiana. Plaintiff and defense cases accepted. CV upon request.
View Full Profile

Patrick H Archie, MD

MDACC-trained medical oncologist & expert witness

OncoLegal Insights, LLC

Missoula, Montana
Oncology - Medical Oncology , Targeted therapy, Deviation from standard of care, Standard of care, Immunotherapy, Misinterpretation of test results, Evidence-based oncology, Toxicity management, Improper treatment selection, Diagnostic workup, Causation analysis, Preventable Cancer Harm, Chemotherapy, Delayed diagnosis
Since graduating Hematology-Oncology fellowship from MD Anderson Cancer Center in 2012, I have worked in academics, hospital-employed positions, private practice, and locum tenens. This exposure to a diverse range of practice environments has allowed me to observe significant variabilities in practice patterns and associated clinical consequences. I have also learned how to communicate complex clinical concepts to patients and family members who may have limited educations and no medical backgrounds. I am committed to delivering top quality patient care, as well as providing expert witness services with the same degree of professional integrity.
View Full Profile

Eric Bravin, MD

Experienced medical oncology expert witness

Milford, New York
Oncology, Hematology - Oncology research, clinical trials, medical oncology, plaintiff witness, defense witness, delayed diagnosis
I have 25 years experience practicing medical oncology with current active board certification and 21 years of experience conducting cancer clinical trials, with a leadership role at the Bassett Cancer Treatment Center in Cooperstown NY. I have been honored for excellence in teaching residents and medical students. I have extensive experience with chemotherapy, immunotherapy and targeted therapy administration and side effect management. I am experienced at performing both plaintiff and defense work and have been deposed both as plaintiff's and defense expert witness.
View Full Profile

Frederick H Hausheer, MD, FACP

Oncology Drug R & D, ICH GCP, Drug Patent Validity

HAUSHEER BIOMED, LLC USA

Austin, Texas
Oncology, Pharmaceutical Regulation - Oncology Drug Development, Patent Validity, ICH GCP, Written description, Enablement, Obviousness, Anticipation, Pharmacology, FDA, EMA, NMPA/China, PMDA/Japan, Drug formulation, Medical Safety, Phase 1-3 Clinical Trials, Drug Product Safety, Medical Oncology, Breach of Contract - Pharma/Biotech, Commercially Reasonable Efforts, Damages
Dr. Frederick (Fred) Hausheer is a physician-scientist with over 37 years of executive leadership and management experience in US and international (EU, JP, China, others) commercial pharmaceutical research and development (Phase I-III), preclinical translational and clinical medicine, clinical pharmacology, ICH GCP compliance and commercial development strategy and risk management of novel cancer therapeutics. His commercial research and development experience includes cytotoxic agents, targeted agents, immuno-oncology therapeutics, cell therapies (BMT, CAR-T), and supportive care medicines. He is an inventor/co-inventor on more than 400 issued United States and international pharmaceutical patents, and author/co-author of more than 200 scientific/medical publications. He is an experienced former CEO and Chief Medical Officer with several biopharma companies and a former NCI-Designated Clinical Investigator, NCI-Institutional Review Board voting member, and NCI-Experimental Ther...